Optimising vaccination strategies in equine influenza

Vaccine

Volumn 21, Issue 21-22, 2003, Pages 2862-2870

  Park, A W ^a,b   Wood, J L N ^a   Newton, J R ^a   Daly, J ^a   Mumford, J A ^a   Grenfell, B T ^b  

^a ANIMAL HEALTH TRUST   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Equine influenza; Stochastic model; Vaccination strategy

Indexed keywords

ANTIBODY; INFLUENZA VACCINE;

AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; HORSE; INFECTION CONTROL; INFLUENZA; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; STOCHASTIC MODEL; VACCINATION; VIRUS TRANSMISSION;

EID: 0038513415     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00156-7     Document Type: Article

References (18)

1. Sarasola P., Taylor D.J., Love S., McKellar Q.A. Secondary bacterial infections following an outbreak of equine influenza. Vet. Rec. 131:1992;441-442.
2. Newton J.R., Lakhani K.R., Wood J.L.N., Baker D.J. Risk factors for equine influenza serum antibody titres in young Thoroughbred racehorses given an inactivated vaccine. Prev. Vet. Med. 46:2000;129-141.
3. de la Rua-Domenech R., Reid S.W.I., González-Zanquiey A.E., Wood J.L.N., Gettinby G. Modelling the spread of a viral infection in equine populations managed in Thoroughbred racehorse training yards. Prev. Vet. Med. 47:2000;61-77.
4. Grenfell BT, Dobson AP, editors. Ecology of infectious diseases in natural populations. Cambridge: Cambridge University Press; 1995.
5. Kermack W.O., McKendrick A.G. A contribution to the mathematical theory of epidemics. Proc. R. Soc. London A. 115:1927;700-721.
6. Bolker B., Grenfell B.T. Chaos and biological complexity in measles dynamics. Proc. R. Soc. London B. 251:1993;75-81.
7. Mumford JA. Control of influenza from an international perspective. In: Proceedings of the Eighth International Conference on Equine Infectious Diseases. 1998. p. 11-24.
8. Glass K., Wood J.L.N., Mumford J.A., Jesset D., Grenfell B.T. Modelling equine influenza 1: a stochastic model of within-yard epidemics. Epidemiol. Infect. 128:2002;491-502.
9. de Tong M.C.M., Kimman J.G. Experimental quantification of vaccine-induced reduction in virus transmission. Vaccine. 12(8):1994;761-766.
10. Longini I.M., Datta S., Halloran M.E. Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-l vaccines. J. AIDS. 13:1996;440-447.
11. Bartlett MS. Monte Carlo studies in ecology and epidemiology. In: Proceedings of the Fourth Berkeley Symposium on Mathematical Statistics and Probability, vol. 4. 1961. p. 39-55.
12. Bell L, editor. Horses in training. London: Raceform; 2002.
13. Mumford J.A., Wood J.M., Scott A.M., Folkers C., Schild G.C. Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8). J. Hygiene. 90:1983;385-395.
14. Mumford J.A., Hannant D., Jessett D.M. Experimental infection of ponies with equine influenza (H3N8) viruses by intranasal inoculation or exposure to aerosols. Eq. Vet. J. 22:1990;93-98.
15. Mumford J.A., Jessett D.M., Rolinson E.A., Hannant D., Draper M.E. Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines. Vet. Rec. 134:1994;158-162.
16. Mumford J.A., Wilson H., Hannant D., Jessett D.M. Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Epidemiol. Infect. 112:1994;421-437.
17. Mumford J.A., Wood J.M., Folkers C., Schild G.C. Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated virus vaccines containing homologous virus. Epiderniol. Infect. 100:1988;501-510.
18. Newton J.R., Townsend H.G.G., Wood J.L.N., Sinclair R., Hannant D., Mumford J.A. Immunity to equine influenza: relationship of vaccine induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Eq. Vet. J. 32(1):2000;65-74.